Grown Rogue International Inc. Share Price
Stocks
GRIN
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Canadian Securities Exchange
20:55:43 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.5300 CAD | -3.64% |
|
-1.85% | -24.29% |
| Market Cap | 93.65M 83.24M 77.16M 70.2M 132M 8.89B 135M 927M 364M 4.64B 351M 344M 14.79B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 109M 96.84M 89.76M 81.67M 154M 10.34B 157M 1.08B 423M 5.4B 409M 400M 17.2B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| GRIN | Delayed | |
OTC Markets
| GRUS.F | Delayed | |
|
Deutsche Boerse AG
| 1VF0 | Delayed |
Last Transcript: Grown Rogue International Inc.
| 1 day | -3.64% | ||
| 1 week | -1.85% | ||
| Current month | -10.17% | ||
| 1 month | -11.67% | ||
| 3 months | -20.90% | ||
| 6 months | +17.78% | ||
| Current year | -24.29% |
| 1 week | 0.52 |  | 0.59 |
| 1 month | 0.52 | | 0.66 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.32 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 14/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 30/09/2016 |
| Director of Finance/CFO | 42 | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 14/11/2018 |
J. Strickler
CHM | Chairman | 45 | - |
Ryan Kee
BRD | Director/Board Member | 42 | 31/12/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/07/26 | Option | Director | 120,000 | 0.0480% | ||
| 21/07/26 | Option | Director | 120,000 | 0.0480% | ||
| 21/07/26 | Free | Founder | 1,000,000 | 0.4001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.64% | -1.85% | -8.62% | +47.22% | 96.83M | |
| +0.43% | +6.59% | +53.41% | +103.85% | 1,116B | |
| +0.90% | -2.25% | +33.02% | +62.23% | 610B | |
| +0.71% | +3.24% | +25.81% | +93.86% | 501B | |
| +0.52% | +0.24% | +73.92% | +40.15% | 358B | |
| -0.13% | +7.51% | +33.47% | +48.68% | 366B | |
| -0.95% | +5.93% | +19.86% | +42.48% | 288B | |
| -1.98% | +4.66% | -1.57% | +13.41% | 261B | |
| -0.35% | +4.25% | +46.21% | +50.76% | 235B | |
| -0.75% | +3.32% | +32.53% | +97.21% | 195B | |
| Average | -0.52% | +4.73% | +30.80% | +59.98% | 392.99B | |
| Weighted average by Cap. | +0.13% | +4.68% | +39.16% | +71.16% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 24.02M 22.26M 20.25M 38.22M 2.56B 38.83M 268M 105M 1.34B 101M 99.24M 4.27B | 32.43M 28.83M 26.72M 24.31M 45.87M 3.08B 46.61M 321M 126M 1.61B 122M 119M 5.12B |
| Net income | -11.3M -10.05M -9.31M -8.47M -15.99M -1.07B -16.25M -112M -43.89M -560M -42.42M -41.52M -1.78B | 1.73M 1.54M 1.43M 1.3M 2.45M 164M 2.49M 17.13M 6.72M 85.67M 6.49M 6.35M 273M |
| Net Debt | 3.7M 3.29M 3.05M 2.78M 5.24M 352M 5.32M 36.69M 14.38M 183M 13.9M 13.61M 585M | 15.3M 13.6M 12.61M 11.47M 21.64M 1.45B 21.99M 152M 59.41M 758M 57.42M 56.2M 2.42B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | CA$0.5300 | -3.64% | 15,406 |
| 15/10/26 | CA$0.5500 | -3.51% | 29,500 |
| 14/10/26 | CA$0.5700 | +1.79% | 23,092 |
| 13/10/26 | CA$0.5600 | -1.75% | 14,000 |
| 09/10/26 | CA$0.5700 | +5.56% | 7,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
